Skip to main content

Imatinib Mesylate Said to Offer Promise for Scleroderma Patients : Tyrosine kinase inhibitor appears to reduce skin thickness and improve lung function.

Primary tabs

View
Get Stamp Tags
Published Locations

Breadcrumb

Home
Imatinib Mesylate Said to Offer Promise for Scleroderma Patients : Tyrosine kinase inhibitor appears to reduce skin thickness and improve lung function.

User login

Username

Password

Reset your password

Type	Lead	score